Skip to main content

Market Overview

CRISPR Therapeutics AG (CRSP)

130.73 +1.53 (1.18%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:
-1.51
539K



Q4 2021
After-Hours
EPS:
REV:
-1.50
370K



Q3 2021
Pre-Market
EPS:
REV:
-1.32
148K



Q2 2021
After-Hours
EPS:
REV:
-1.30
44K



Q1 2021
After-Hours
EPS:
REV:
-1.15
157K
-1.47
1.14M
-1.51
539K
-2.72%
Q4 2020
After-Hours
EPS:
REV:
0.51
77.017M
-1.27
2.32M
-1.50
370K
-18.11%
-84.05%
Q3 2020
Pre-Market
EPS:
REV:
2.4
211.928M
-1.18
2.06M
-1.32
148K
-11.86%
-92.82%
Q2 2020
After-Hours
EPS:
REV:
-1.01
318K
-0.95
18.12M
-1.30
44K
-36.84%
-99.76%
Q1 2020
After-Hours
EPS:
REV:
-0.93
328K

-1.15
157K

Q4 2019
After-Hours
EPS:
REV:
-0.92
115K

0.51
77.017M

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!